Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 64,616 shares at $32.29 ($2.1M) on 2021-07-07, disclosed to the SEC on 2021-07-08.
Open-market sale of $2.1M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.99 | 1,884 | $60K | 2.9% |
| 2 | $31.99 | 1,884 | $60K | 2.9% |
| 3 | $32.29 | 30,424 | $982K | 47.1% |
| 4 | $32.29 | 30,424 | $982K | 47.1% |
| Total | $32.27 avg | 64,616 | $2.1M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |